检索

标题
作者
Non-alcoholic fatty liver disease and its role in the development of cardiovascular diseases
Dora S., Semikova G., Shvets Z., Cherebillo I., Khoshafyan N.
Assessment of comorbid pathology in patients with breast cancer
Orlova D., Stolyarova V., Skopina Y., Shokina S., Davydova E.
Syphilis in the practice of a cardiologist
Mikhailova Z., Ivanova I.
Statins in the treatment of patients with peripheral artery diseases: strategy and tactics of appointment
Paranina Е., Krivoshchekov Е., Paranin P.
Psychodynamic aspects of some cardiac diseases: a cardiologist’s opinion
Eremeev A.
Epicardial fat ectopy in women with different estradiol levels
Zimina M., Dora S., Lygdenova I., Yusipova T., Butomo M., Volkova A., Khalimov Y.
The effect of hypertension on the course and severity of psoriasis
Muminova M., Zhukova O., Dvoryankova E., Korsunskaya I.
Features of groups of patients with endovascular intervention
Titova A., Andreeva E., Martynova T., Kozyrev O.
Current data on the role of homocysteine in the formation of cardiovascular diseases
Dudnikova А., Sokolova Е., Poltorackaya P., Storozhenko А., Simakov D., Dorohin Z.
Possibility of using Femoklim in menopause women with cardiovascular pathologies
Dedov D., Denisova A., Moiseeva I., Petrova E., Poluboyarinov P., Vikhrev D., Panina E., Fedorov A., Burmistrova S.
Erectile dysfunction in men with cardiovascular disease: the possibility of prevention with Eromax
Dedov D.
Sulodexide in clinical practice: possibilities and prospects of its use
Morozov A., Sergeev A., Boltik A., Aslakhanova E., Ispieva K.
Cardiotone: pharmacological properties of hawthorn blood-red, possibility of use in patients with cardiovascular diseases
Dedov D.
OVERVIEW OF MOBILE APPLICATIONS USED BY PHYSICIANS AND PATIENTS WITH CARDIOVASCULAR DISEASES
Rozhnev V., Duvanova S., Sadovnikov A., Zakutnaya E., Gorbunova E.
The drug Cardioton: composition, pharmacological properties, the possibilities of preventing cardiovascular diseases
Dedov D.
Cardiometabolic and anti-ischemic therapy for cardiovascular disease and estrogen deficiency
Khabibulina M.
Comprehensive prevention of age-related and cardiovascular diseases: the use of the Russian natural remedy BioDihydroquercetin of the Baikal Legend trade mark
Dedov D.
The role of uric acid in the development of cardiovascular diseases: from molecular mechanisms to clinical manifestations
Kunitskaya N., Ariev A., Nemirovskiy V.
Anti-ischemic and cardiometabolic therapy in cardiovascular pathology
Khabibulina M., Elistratov D., Shamilov M.
Structured programs for the management of patients with non-alcoholic fatty liver disease in the work of a general practitioner
Skvortsov V., Ustinova M.
Comorbidity in patients with type 2 diabetes mellitus
Voloshinova E., Lobanova O., Kunitsyna M., Grlgoryeva E., Tsaturova K.
AN IDEAL CARDIOVASCULAR RISK BIOMARKER - WHAT IS IT?
Dyleva Y., Gruzdeva O., Uchasova E.
Somatoform disorders in cardiac practice
Eremeev A.
Trends in risk factors for cardiovascular events in patients undergoing kidney transplantion
Martirosyan S., Kosmacheva E.
BIOLOGICAL MARKERS OF CARDIOVASCULAR RISK IN DIABETES MELLITUS
Berezin A.
A DIFFERENTIATED APPROACH TO PRESCRIBING DIPEPTIDYL PEPTIDASE-4 INHIBITORS
Verbovoy A., Dolgikh Y., Pashentseva A.
EFFICIENCY OF MONITORING THE RISK FACTORS OF CARDIOVASCULAR DISEASES IN REAL CLINICAL PRACTICE
Semenova Y., Karpov A., Litvinenko T., Borisova E., Takhausov R.
PANANGIN IN THE ARSENAL OF A GENERAL PRACTITIONER
Lebedeva M.
Hypertrophic cardiomyopathy and pregnancy
Ignatenko G., Taradin G., Kugler T.
Cardiovascular diseases prediction by integrated risk factors assessment by means of machine learning
Gavrilov D., Serova L., Korsakov I., Gusev A., Novitsky R., Kuznetsova T.
AGE-RELATED CHANGES IN CARDIOVASCULAR RISK FACTORS IN MEN AND WOMEN
Gruzdeva O., Palicheva E., Maksimov S., Zhilyaeva T., Dyleva Y., Makarov S.
CARDIOMAGNYL: EFFICACY AND SAFETY
Potupchik T., Veselova O., Evert L., Okladnikova E., Anisimova M., Bryukhanova I.
CORRECTION OF COGNITIVE IMPAIRMENTS IN DYSCIRCULATORY ENCEPHALOPATHY IN THE PRESENCE OF CARDIOVASCULAR DISEASE
Flrsov A., Flrsova S., Usanova T., Kusaikin A., Volodina V.
THE POSITIVE ROLE OF OBESITY IN THE CLINICAL PRESENTATION OF VISCERAL DISEASES
Noskov S., Sherina T., Pryanlchnlkova A.
Hypertension and erectile dysfunction: management tactics
Mikhailova Z., Stroganov A.
Coronary atherosclerosis in women with ST segment elevation acute coronary syndrome in the Republic of Sakha (Yakutia)
Kylbanova E., Pavlova A., Guryeva E., Dokunaev V.
Analysis of pharmacotherapy for hypertension in terms of overall cardiovascular risk
Potupchik T., Veselova O., Evert L., Makarova M., Averyanova O.
EPIDEMIOLOGY OF HYPERTENSION IN WORKING WOMEN
Elgarov A., Kalmykova M., Apsheva E., Elgarov M., Shogenova A.
RISK FACTORS FOR CARDIOVASCULAR DISEASES AND THE RATE OF AGEING IN MEN
Golovanova E.
OSTEOPOROSIS IN PATIENTS WITH CORONARY HEART DISEASE AND HYPERTENSION
Bolotnova T., Platltsyna N., Kuslivaya O.
LATE-ONSET ASTHMA: SPECIFIC FEATURES OF ITS CLINICAL PRESENTATION AND MANAGEMENT TACTICS IN OUTPATIENT SETTINGS
Shaporova N., Trofimov V., Pelevina I., Yablonskaya V., Baranova O.
Cause-of-death coding as a factor influencing mortality rates from individual causes
Samorodskaya I.
Mutually reinforcing triad: depression, erectile dysfunction and cardiovascular pathology in men
Petrova E., Herzog N., Baranova G., Nesterenko E., Maltseva T., Koldova T., Poluboyarinov P.
A rational approach to solving cardiometabolic problems in the therapy of comorbid patients
Shishkova V., Kapustina L.
INSULIN RESISTANCE AND DISEASES OF THE INTERNAL ORGANS
Verbovoy A., Sharonova L., Pashentseva A., Verbovaya N., Galkin R.
CONTROL OF CARDIOVASCULAR DISEASES IN RURAL DWELLERS: SURVEY RESULTS
Gomova T., Soin I., Kushunina D., Kalinina A.
ATTENTION! A MOTOR TRANSPORT DRIVER AT THE RECEPTION
Elgarov A., Kalmykova M., Elgarov M.
BISOPROLOL IN PATIENTS WITH CARDIOVASCULAR DISEASES
Zadionchenko V., Shekhyan G., Yalymov A.
SUBCLINICAL FORMS OF CARDIOVASCULAR DISEASES IN APPARENTLY HEALTHY ABLE-BODIED INDIVIDUALS
Dokina E., Volkova N., Kravtsova N., Alekseeva L.
MAIN GROUPS OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITORS: MECHANISMS OF ACTION AND CLINICAL EFFICACY. PART 2
Chaulin A., Svechkov N., Volkova S.
Hypertensive angiopathy of the retina as a marker of cardiovascular risk
Shcherbakova K., Yasenovets M., Barsukov A.
Gender features of myocardial structural and functional changes in patients with chronic glomerulonephritis at the predialysis stage of the disease
Murkamilov I., Aitbaev K., Fomin V., Rayimzhanov Z., Redzhapova N., Yusupov F., Aidarov Z.
CARDIOVASCULAR CHANGES IN PRETERM INFANTS WITH PERINATAL PATHOLOGY
Yarukova E., Panova L.
ESTIMATION OF THE BENEFIT OF ACETYLSALICYLIC ACID IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES
Napalkov D.
IMPACT OF ANTIHYPERTENSIVE THERAPY ON THE PARAMETERS OF VASCULAR WALL STIFFNESS AS A RISK FACTOR OF CARDIOVASCULAR DISEASES
Gushchina Y.
THE EFFICIENCY, SAFETY, AND TOLERANCE OF ROSUVASTATIN THERAPY IN VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: PRELIMINARY RESULTS OF THE 40x40 STUDY
Zubareva M., Rozhkova T., Gornyakova N., Solovyeva E., Susekov A., Kukharchuk V.
Main groups of proprotein convertase subtilisin/kexin type 9 inhibitors: mechanisms of action and clinical efficacy. Part 1
Chaulin A., Svechkov N., Volkova S.
IMPACT OF STRESS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES
Potupchik T., Evert L., Averyanova O., Akhmeldinova Y.
Safe therapy for joint and back pain in a patient with comorbidity
Shishkova V.
COENZYME Q10 WITH GINKGO IN CARDIOLOGY PRACTICE
Potupchlk T., Veselova O., Evert L., Makarova M.
SAFE THERAPY FOR OSTEOARTHRITIS IN PATIENTS WITH COMORBIDITIES
Shishkova V.
CHRONIC OBLITERATING DISEASES OF THE LOWER EXTREMITY ARTERIES: PROGNOSTIC VALUE OF CARDIOVASCULAR RISK FACTORS
Lazutkina A., Gorbunov V.
A CASE OF POLYARTERITIS NODOSA
Dragomlretskaya N., Matveev V., Podzolkov V., Piskunov D., Shulutko A., Seredln V.
POTASSIUM AND MAGNESIUM PREPARATIONS IN ROUTINE CLINICAL PRACTICE
Kubynin A.
Features of the course of cardiovascular pathology and type 2 diabetes mellitus in patients with COVID-19
Polozova E., Skvortsov V., Chegodaeva L., Kurkina N., Prokhorova T., Al-Zakhar N., Nefedov N.
Assessment of autonomic regulation of the cardiovascular system in adolescent boys of pre-draft age
Pshenichnaya E.
COMORBIDITY AND POLYPRAGMACY
Shlshkova V.
ADIPONECTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS
Pashentseva A., Verbovoy A., Sharonova L.
TREATMENT OF MILD AND MODERATE MAJOR DEPRESSIVE DISORDER WITH VALDOXANE (AGOMELATINE) IN PATIENTS WITH CARDIOVASCULAR DISORDERS: RESULTS OF THE NATIONAL OBSERVATIONAL MULTICENTER STUDY «PULSE»
Medvedev V.
BISOPROLOL IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
Shavarov A.
High-risk hypertension: efficacy of combination antihypertensive drug and non-drug antihypertensive therapy
Khamidullaeva G., Khafizova L., Abdullaeva G.
Modern pharmacotherapy of type 2 diabetes mellitus: focus on empagliflozin
Skvortsov V., Levitan B., Sabanov A., Skvortsova E., Bangarov R.
Occupational and work-related lesions of the cardiovascular system: problems of causation
Strizhakov L., Babanov S., Borisova D., Agarkova A., Ostryakova N., Kiryushina T.
CARDIOPULMONARY COMORBIDITIES IN PATIENTS WITH NEW-ONSET TU-BERCULOSIS IN THE PRESENCE OF CHRONIC OBSTRUCTIVE PULMONARY DIS-EASE
Baglsheva N., Mordyk A., Ivanova O., Rudenko S., Ibragimova M., Ibragimova A.
COMBINED THERAPY FOR PANIC DISORDERS IN CARDIOLOGY PRACTICE
Vasilyeva A., Karavaeva T., Poltorak S.
LEPTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS
Pashentseva A., Verbovoy A., Kosareva O.
HEMATOLOGIC ONCOLOGY: CARDIOVASCULAR COMPLICATIONS OF CHEMOTHERAPY
SHUIKOVA K., MAKEEVA L., EMELINA E., LEPKOV S., GENDLIN G., STOROZHAKOV G.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN REAL PRACTICE: INEQUALITY OF EQUALS
Chernyavskaya T.
Prevalence of cardiovascular risk factors in the staff of a large industrial enterprise
Semenova Y., Karpov A., Trivozhenko A., Smirnova I., Takhauov A., Efimova E., Takhauov R.
The main aspects of using magne preparations in complex therapy of a comorbid patient with arterial hypertension
Skvortsov V., Sabanov A., Rodionova I., Gorbach A.
Prevalence, risk factors, and diagnosis of comorbidity of chronic obstructive pulmonary disease and cardiovascular disease
Chaulin A., Milyutin I., Duplyakov D.
1 - 81 的 81 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##